These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 21604240)
1. Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats. Ardjomand-Woelkart K; Kollroser M; Magnes C; Sinner F; Frye RF; Derendorf H; Bauer R; Butterweck V Planta Med; 2011 Nov; 77(16):1794-9. PubMed ID: 21604240 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides after oral administration in rats. Woelkart K; Frye RF; Derendorf H; Bauer R; Butterweck V Planta Med; 2009 Oct; 75(12):1306-13. PubMed ID: 19399718 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract. Guiotto P; Woelkart K; Grabnar I; Voinovich D; Perissutti B; Invernizzi S; Granzotto M; Bauer R Phytomedicine; 2008 Aug; 15(8):547-54. PubMed ID: 18583121 [TBL] [Abstract][Full Text] [Related]
4. Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture. Dietz B; Heilmann J; Bauer R Planta Med; 2001 Dec; 67(9):863-4. PubMed ID: 11745026 [TBL] [Abstract][Full Text] [Related]
5. The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS. Goey AK; Rosing H; Meijerman I; Sparidans RW; Schellens JH; Beijnen JH J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():151-6. PubMed ID: 22770780 [TBL] [Abstract][Full Text] [Related]
6. Possible role of fat tissue in the pharmacokinetics of Dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral administration of Echinacea angustifolia extract in rats. Jedlinszki N; Rédei D; Haller J; Freund TF; Hohmann J; Zupkó I Nat Prod Commun; 2014 Jun; 9(6):843-5. PubMed ID: 25115096 [TBL] [Abstract][Full Text] [Related]
7. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans. Woelkart K; Koidl C; Grisold A; Gangemi JD; Turner RB; Marth E; Bauer R J Clin Pharmacol; 2005 Jun; 45(6):683-9. PubMed ID: 15901750 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans. Woelkart K; Dittrich P; Beubler E; Pinl F; Schoop R; Suter A; Bauer R Planta Med; 2008 May; 74(6):651-6. PubMed ID: 18240099 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system. Woelkart K; Marth E; Suter A; Schoop R; Raggam RB; Koidl C; Kleinhappl B; Bauer R Int J Clin Pharmacol Ther; 2006 Sep; 44(9):401-8. PubMed ID: 16995328 [TBL] [Abstract][Full Text] [Related]
10. Purification of alkylamides from Echinacea angustifolia (DC.) Hell. Roots by high-speed countercurrent chromatography. Lopes-Lutz D; Mudge E; Ippolito R; Brown P; Schieber A J Agric Food Chem; 2011 Jan; 59(2):491-4. PubMed ID: 21190380 [TBL] [Abstract][Full Text] [Related]
11. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations. Livesey J; Awang DV; Arnason JT; Letchamo W; Barrett M; Pennyroyal G Phytomedicine; 1999 Nov; 6(5):347-9. PubMed ID: 11962542 [TBL] [Abstract][Full Text] [Related]
12. Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants. Hou CC; Chen CH; Yang NS; Chen YP; Lo CP; Wang SY; Tien YJ; Tsai PW; Shyur LF J Nutr Biochem; 2010 Nov; 21(11):1045-59. PubMed ID: 20005088 [TBL] [Abstract][Full Text] [Related]
13. Transport of alkamides from Echinacea species through Caco-2 monolayers. Jager H; Meinel L; Dietz B; Lapke C; Bauer R; Merkle HP; Heilmann J Planta Med; 2002 May; 68(5):469-71. PubMed ID: 12058332 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract formulated in softgel capsules. Dall'Acqua S; Perissutti B; Grabnar I; Farra R; Comar M; Agostinis C; Caristi G; Golob S; Voinovich D Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):8-14. PubMed ID: 26455420 [TBL] [Abstract][Full Text] [Related]
15. Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytes. Kotowska D; El-Houri RB; Borkowski K; Petersen RK; Fretté XC; Wolber G; Grevsen K; Christensen KB; Christensen LP; Kristiansen K Planta Med; 2014 Dec; 80(18):1712-20. PubMed ID: 25371981 [TBL] [Abstract][Full Text] [Related]
17. LC-MS N-alkylamide profiling of an ethanolic Anacyclus pyrethrum root extract. Boonen J; Sharma V; Dixit VK; Burvenich C; De Spiegeleer B Planta Med; 2012 Nov; 78(16):1787-95. PubMed ID: 23047251 [TBL] [Abstract][Full Text] [Related]
18. Chromatographic methods for metabolite profiling of virus- and phytoplasma-infected plants of Echinacea purpurea. Pellati F; Epifano F; Contaldo N; Orlandini G; Cavicchi L; Genovese S; Bertelli D; Benvenuti S; Curini M; Bertaccini A; Bellardi MG J Agric Food Chem; 2011 Oct; 59(19):10425-34. PubMed ID: 21830789 [TBL] [Abstract][Full Text] [Related]
19. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells. Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous analysis of caffeic acid derivatives and alkamides in roots and extracts of Echinacea purpurea by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry. Luo XB; Chen B; Yao SZ; Zeng JG J Chromatogr A; 2003 Jan; 986(1):73-81. PubMed ID: 12585324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]